Finance
Medical devices company reports second quarter 2004 financial results
Published in Medical Devices and Surgical Technology Week, August 22nd, 2004
Eps from normal operations for the most recent four calendar quarters (LTM) were $1.51. Including "extraordinary" income from 4Q 2003 and 1Q 2004, LTM eps were $4.93. The extraordinary income results from receipt of Tyco International damages and interest of $30,944,000 relating to patent infringement.
UTMD's 2Q 2004 sales were about the same as 2Q 2003, a recovery from 1Q 2004 when sales were down 4% compared to 1Q 2003. Combining the two quarters, 1H 2004 sales...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
More Articles from Medical Devices and Surgical Technology Week
- Brucellosis
Novel immunoassay facilitates diagnosis in food animals - Neuroscience
CE-LIFD microdialysis suitable for surgical neurotransmitter monitoring - Orthodontics
Zygomatic skeletal anchorage effective in open bite treatment - RNA Research
Tape-harvested RNA samples suitable for microarray analysis - AIDS/HIV Diagnosis
Performance of rapid HIV antibody detection assays evaluated - Acute Pancreatitis
Endothelial nitric oxide synthase is protective in mice - More from this issue of Medical Devices and Surgical Technology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
